VALPARAISO | The da Vinci robotic surgical platform n the technology that sparked a revolutionary change in prostate cancer surgery n is proving to be just as ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results